ReShape Lifesciences Inc. (RSLS)

NASDAQ: RSLS · IEX Real-Time Price · USD

0.211

-0.009 (-3.95%)

At close: Jul 19, 2024, 4:00 PM

0.210

-0.001 (-0.61%)

Pre-market: Jul 22, 2024, 8:57 AM EDT

ReShape Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Market Capitalization	6	3	3	29	12	15	Upgrade
Market Cap Growth	-42.09%	0.64%	-88.83%	150.22%	-20.27%	-69.66%	Upgrade
Enterprise Value	4	-1	-1	7	22	2	Upgrade
PE Ratio	-	-0.29	-0.07	-0.46	-0.54	-0.62	Upgrade
PS Ratio	0.75	0.38	0.29	2.15	1.03	4.46	Upgrade
PB Ratio	1.37	0.49	0.89	0.66	0.81	0.92	Upgrade
P/FCF Ratio	-0.17	-0.19	-0.15	-1.85	-1.30	-0.63	Upgrade
P/OCF Ratio	-0.17	-0.19	-0.15	-1.90	-1.36	-0.64	Upgrade
EV/Sales Ratio	0.48	-0.12	-0.05	0.49	1.94	0.52	Upgrade
EV/EBITDA Ratio	-0.02	0.09	0.01	-0.11	-1.21	-0.08	Upgrade
EV/EBIT Ratio	-0.02	0.09	0.01	-0.11	-1.11	-0.07	Upgrade
EV/FCF Ratio	-0.01	0.06	0.02	-0.42	-2.45	-0.07	Upgrade
Debt / Equity Ratio	0.05	0.04	0.05	0.01	0.91	0.07	Upgrade
Debt / EBITDA Ratio	-0.02	-0.02	0.00	0.00	-0.73	-0.05	Upgrade
Debt / FCF Ratio	-0.02	-0.02	-0.01	-0.02	-1.48	-0.05	Upgrade
Quick Ratio	1.15	1.65	0.82	3.40	0.48	3.61	Upgrade
Current Ratio	2.24	2.73	1.33	3.98	0.77	4.59	Upgrade
Asset Turnover	0.86	0.74	0.35	0.19	0.55	0.14	Upgrade
Interest Coverage	-	-	-411.34	-75.23	-9.64	-60.50	Upgrade
Return on Equity (ROE)	-207.80%	-187.90%	-193.40%	-131.70%	-223.80%	-186.40%	Upgrade
Return on Assets (ROA)	-113.20%	-97.50%	-143.50%	-90.00%	-105.40%	-98.00%	Upgrade
Return on Capital (ROIC)	-250.60%	-222.14%	-1209.58%	-129.74%	-44.90%	-137.19%	Upgrade
Earnings Yield	-175.74%	-347.17%	-1418.05%	-216.51%	-185.57%	-161.95%	Upgrade
FCF Yield	-224.94%	-517.39%	-674.87%	-53.92%	-76.70%	-157.73%	Upgrade
Buyback Yield / Dilution	-1273.25%	-1303.56%	-94.21%	-179.82%	-148.88%	-147.23%	Upgrade
Total Shareholder Return	-1273.25%	-1303.56%	-94.21%	-179.82%	-148.88%	-147.23%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).